California’s Involuntary Commitment for Substance Use “Amid the ongoing debate over the utility of [involuntary commitment] IC as a tool to treat severe substance use disorders and legislation expanding IC for substance use disorders (SUDs) in California and other states, this article highlights the need to better study the use and effectiveness of existing legislation as well as to consider upstream interventions, such as expansion of community-based treatment models.” Weiner, S. L., Bal, B., Hirschtritt, M. E., & Barnard, A. (2024). Insights from California on involuntary commitment for substance use. The Journal of the American Academy of Psychiatry and the Law. https://lnkd.in/ewJj_FZt
Forensic Psychiatry Institute’s Post
More Relevant Posts
-
The National University of Science and Technology (NUST) joins the World in the fight against Drug and Substance Abuse. The 2024 global theme is: “The Evidence is Clear: Invest in Prevention”. As we join the world in investingin prevention against drug and substance abuse, the University is carrying out various activities including running a Video Series Campaign with an expert, Dr Nemache Mawere, the Chief Executive Officer of Ingutsheni Central Hospital and Chairperson of the Department of Psychiatry, Social and Behavioural Sciences at NUST. The Awareness Campaign addresses the following: Episode1: Types of drugs and substances. https://lnkd.in/dJugtsqz orscantheQRCode Episode2: Causes of drug and substance abuse. https://lnkd.in/d93mKUDQ orscantheQRCode #choosenust #studyatnust #ThinkInOtherTerms #stopdrugandsubstanceabuse
-
-
Join us for the captivating session, "Bridging the Paradigms of Modern Science and Traditional Healing with Psychedelic Interventions," at the Emerging Themes in Behavioral Health Conference from April 17 – 19, 2024. This Friday morning session is an opportunity to gain insights into the future of behavioral health and the evolving landscape of psychedelic-assisted therapy. Our distinguished panel of experts, Dr.Joe Tafur, MD, Dr. Gita Vaid, MD, and Dr. Markus Rogan, PsyD, LMFT, will have a captivating discussion navigating the intricate landscape of psychedelic therapy, exploring vital aspects such as set and setting, integration, and the complex interplay of legality around clinician training and treatment provision. The panel will also be considering the impact of the involvement of HMOs/Insurance and questioning the optimal institutional framework for psychedelics, straddling the realms of psychology, psychiatry, and medicine. The audience can engage with our speakers as we dissect the politics of legalization and grapple with accountability for nontraditional practitioners in this groundbreaking therapeutic frontier. Registration ends next week! So, don't miss this chance to delve into psychedelic-assisted therapy and be a part of the future of behavioral health. To register, click the link in the comments. #ETBHC2024 #BehavioralHealthConference #PsychedelicTherapy #FutureOfBehavioralHealth
-
-
Join us for the captivating "Bridging the Paradigms of Modern Science and Traditional Healing with Psychedelic Interventions" session at the Emerging Themes in Behavioral Health Conference from April 17 – 19, 2024. This Friday morning session is an opportunity to gain insights into the future of behavioral health and the evolving landscape of psychedelic-assisted therapy. Our distinguished panel of experts, Dr.Joe Tafur, MD, Dr. Gita Vaid, MD, and Dr. Markus Rogan, PsyD, LMFT, will have a captivating discussion navigating the intricate landscape of psychedelic therapy, exploring vital aspects such as set and setting, integration, and the complex interplay of legality around clinician training and treatment provision. The panel will also be considering the impact of the involvement of HMOs/Insurance and questioning the optimal institutional framework for psychedelics, straddling the realms of psychology, psychiatry, and medicine. The audience can engage with our speakers as we dissect the politics of legalization and grapple with accountability for nontraditional practitioners in this groundbreaking therapeutic frontier. Registration ends next week! So, don't miss this chance to delve into psychedelic-assisted therapy and be a part of the future of behavioral health. To register, click the link in the comments. #ETBHC2024 #BehavioralHealthConference #PsychedelicTherapy #FutureOfBehavioralHealth
-
-
Upcoming Webinar Alert: The Youth Protective Factors Study Oct 2, 2024 at 2pm ET. Register: https://lnkd.in/efPPgx9R Our Implementation Science and Practice Advances Research Center (iSPARC) Law & Psychiatry Co-Director, Gina Vincent, PhD and colleagues from CSG Justice Center and University of California, Berkeley's Risk Resilience Research present the initial findings from this important study. We'll explore youth reoffending, risk factors and services that work. Let's improve outcomes for #YoungAdults involved in the #JuvenileJustice system! #ProtectiveFactors #ImproveYouthOutcomes
-
-
Mental Health Nurse Promoter | Project Coordinator | OSCE Educator| BLS Trainer | Researcher | RCN Learning Representative | Optimizing Digital Strategies to Promote Nursing Care, Patient Outcomes and Healthcare Services
Of course, Digital Mental Health care is becoming a global innovative perspective and this Symposium discussion is a great step made by Elysium Healthcare. Looking foward to it.
It’s only a few days until Elysium’s first Psychiatry Symposium webinar, which will be held on Thursday 27th June, and places are booking up fast! This webinar is part of a global series curated with Ramsay Mental Health Australia. During this session, colleagues across the organisation will hear from Dr Quazi Haque, Elysium’s Chief Medical Officer and Executive Operations Director, who will be joined by special expert guest, Dr Michelle Tempest, author of ‘Big Brain Revolution’. They will be discussing the interesting topic of ‘Digital Mental Health Care - Global Perspectives: What’s hype and what’s happening – An exploration of innovation, evidence and ethics’.
-
-
In 2024 we have been working to make the Department of Psychiatry as welcoming and inclusive as possible. Some of the steps we have taken to improve our working culture include: ➡️ introducing an application process for open-ended contracts to help address some of the uncertainty of fixed term contracts. ➡️ holding PI (Principal Investigator) lunches to encourage senior leaders to discuss key issues, share best practice and learn from each other. ➡️ introduced termly People and Culture themes to enable us to be more strategic and focused on key areas. After having our Athena Swan Silver Award renewed this year, as we head into 2025 we will be starting to implement and deliver on our future action plan. Read more about our People and Culture highlights from the past year from our Associate Head of Department for People and Culture Professor Catherine Harmer 👇 https://lnkd.in/esGmwZe5
-
-
Dr. Monica Swahn and colleagues have published a pivotal study in Health Promotion International addressing alcohol use disorders among healthcare professionals. The research highlights the high prevalence of these disorders, exacerbated by the COVID-19 pandemic, and emphasizes their impact on productivity, health, and patient care quality. The study calls for urgent interventions, including evidence-based training, organizational support, and integration of alcohol use screening and treatment into primary healthcare and psychiatry services. It also identifies a significant gap in research from low- and middle-income countries. These findings underscore the need for a comprehensive approach to improve workforce well-being and ensure the delivery of high-quality care. Read the full article: https://ow.ly/QNeH50UjmEg. #WCHHS #FacultySpotlight #Publications #ThisIsWellstarCollege #SocialWork #HumanServices #kennesawstate
-
-
It was great to connect with and hear from old friends and new at the Horizons Business Forum last week. The start of the year has been a busy one for psychiatry, with advances made in driving potential future access to novel mental health treatments, and it was good to talk through what this means for the industry moving forward. One of the key topics of discussion was the new category III CPT codes, which were made live this year, and it was great to see recognition that they represent a critical component of the reimbursement framework for HCPs should psychedelic treatments be approved. This was particularly timely as last week also saw the publication of new peer reviewed guidance (see link in first comment) on the use of these codes in psychedelic treatments. This guidance directs the health care industry to proactively support access through specific current use cases for the new codes. Whilst we urgently develop new treatments for those living with serious mental illness, we also need to find ways to ensure broad and equitable access to them in the future, and category III CPT codes are a positive step in making this happen.
-
Are you aware of the bottlenecks affecting your psychiatry office? Unlock a more efficient practice by applying the Theory of Constraints (TOC): ✅ Identify and address the biggest bottleneck in your operations for improved performance. ✅ Balance profitability and patient care by clearly defining your practice management goals. ✅ Understand the interconnected systems of patient care and revenue generation to streamline operations. Learn more about using TOC for your practice: https://hubs.ly/Q02_PDJk0 #PracticeManagement #HealthcareEfficiency #RevenueGrowth #TheoryOfConstraints #MentalHealthCare #HealthcareInnovation
-
This morning, marketing manager (and Lancaster Chamber Ambassador) Jason Konopinski had the privilege of attending the press conference and ribbon cutting for Penn Medicine Lancaster General Health's new Behavioral Health Center -- Lancaster County's FIRST center for low-risk behavioral health patients seeking care for depression, anxiety, substance-abuse disorders, and other mental health concerns that do not require inpatient or emergency care. The new Crisis Walk-In Center will build an important bridge to ongoing care, including counseling and medication management and the addition of interventional psychiatry services, including innovative TMS, intranasal and IV ketamine, and ECT.
-
